ID HRSL3_HUMAN Reviewed; 162 AA. AC P53816; Q3SYI3; Q9HDD1; DT 01-OCT-1996, integrated into UniProtKB/Swiss-Prot. DT 31-JAN-2002, sequence version 2. DT 23-JAN-2007, entry version 48. DE HRAS-like suppressor 3 (H-rev 107 protein homolog) (HREV107-3) (Renal DE carcinoma antigen NY-REN-65). GN Name=HRASLS3; Synonyms=HREV107; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY. RC TISSUE=Liver; RX MEDLINE=98442971; PubMed=9771974; DOI=10.1038/sj.onc.1202060; RA Husmann K., Sers C., Fietze E., Mincheva A., Lichter P., Schafer R.; RT "Transcriptional and translational downregulation of H-REV107, a class RT II tumour suppressor gene located on human chromosome 11q11-12."; RL Oncogene 17:1305-1312(1998). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA]. RA Kato S.; RT "Human cDNA encoding H-REV107 protein homolog."; RL Submitted (AUG-1999) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [MRNA]. RC TISSUE=Testis; RA Siegrist S., Feral C., Chami M., Solhonne B., Rajpert-De Meyts E., RA Guellaen G., Bulle F.; RT "Homo sapiens testis HREV107-3 mRNA."; RL Submitted (OCT-2000) to the EMBL/GenBank/DDBJ databases. RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Colon; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA RT project: the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [5] RP IDENTIFICATION AS A RENAL CANCER ANTIGEN. RC TISSUE=Renal cell carcinoma; RX MEDLINE=99438124; PubMed=10508479; RX DOI=10.1002/(SICI)1097-0215(19991112)83:4<456::AID-IJC4>3.0.CO;2-5; RA Scanlan M.J., Gordan J.D., Williamson B., Stockert E., Bander N.H., RA Jongeneel C.V., Gure A.O., Jaeger D., Jaeger E., Knuth A., Chen Y.-T., RA Old L.J.; RT "Antigens recognized by autologous antibody in patients with renal- RT cell carcinoma."; RL Int. J. Cancer 83:456-464(1999). RN [6] RP FUNCTION, AND TISSUE SPECIFICITY. RX PubMed=11973642; DOI=10.1038/sj.onc.1205377; RA Sers C., Husmann K., Nazarenko I., Reich S., Wiechen K., RA Zhumabayeva B., Adhikari P., Schroder K., Gontarewicz A., Schafer R.; RT "The class II tumour suppressor gene H-REV107-1 is a target of RT interferon-regulatory factor-1 and is involved in IFNgamma-induced RT cell death in human ovarian carcinoma cells."; RL Oncogene 21:2829-2839(2002). CC -!- FUNCTION: Tumor suppressor that may be involved in interferon- CC dependent cell death. CC -!- TISSUE SPECIFICITY: Ubiquitously expressed with the exception of CC haematopoetic cells. Consistently down-regulated in tumorigenic CC human cell lines. Found in normal ovarian epithelial cells but CC down-regulated in ovarian carcinomas. CC -!- SIMILARITY: Belongs to the H-rev107 family. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; X92814; CAA63423.1; -; mRNA. DR EMBL; AB030814; BAB08108.1; -; mRNA. DR EMBL; AF317086; AAL26892.1; -; mRNA. DR EMBL; BC001387; AAH01387.1; -; mRNA. DR EMBL; BC103807; AAI03808.1; -; mRNA. DR Ensembl; ENSG00000176485; Homo sapiens. DR KEGG; hsa:11145; -. DR H-InvDB; HIX0019647; -. DR HGNC; HGNC:17825; HRASLS3. DR LinkHub; P53816; -. DR ArrayExpress; P53816; -. DR GermOnline; ENSG00000176485; Homo sapiens. DR RZPD-ProtExp; I0553; -. DR RZPD-ProtExp; IOH3962; -. DR RZPD-ProtExp; RZPDo839B04149; -. DR RZPD-ProtExp; RZPDo839B04150; -. DR InterPro; IPR007053; NC. DR Pfam; PF04970; NC; 1. KW Anti-oncogene; Cell cycle; Membrane; Transmembrane. FT CHAIN 1 162 HRAS-like suppressor 3. FT /FTId=PRO_0000152484. FT TRANSMEM 134 154 Potential. FT CONFLICT 90 90 S -> T (in Ref. 1). SQ SEQUENCE 162 AA; 17937 MW; 3565BFC756A6DA3C CRC64; MRAPIPEPKP GDLIEIFRPF YRHWAIYVGD GYVVHLAPPS EVAGAGAASV MSALTDKAIV KKELLYDVAG SDKYQVNNKH DDKYSPLPCS KIIQRAEELV GQEVLYKLTS ENCEHFVNEL RYGVARSDQV RDVIIAASVA GMGLAAMSLI GVMFSRNKRQ KQ //